Related Articles
Implications of driver genes associated with a high tumor mutation burden identified using next‑generation sequencing on immunotherapy in hepatocellular carcinoma
Comprehensive characterization of cancer genes in hepatocellular carcinoma genomes
Peripheral blood neutrophil count as a prognostic factor for patients with hepatocellular carcinoma treated with sorafenib
Alcohol dehydrogenase 4 is a TP53‑associated gene signature for the prediction of prognosis in hepatocellular carcinoma
Sorafenib/MEK inhibitor combination inhibits tumor growth and the Wnt/β‑catenin pathway in xenograft models of hepatocellular carcinoma